Trial finds coronary bioadaptor offers a significant reduction in adverse clinical events
Undergoing percutaneous coronary intervention (PCI) for narrowed arteries with a novel bioadaptor is at least as effective as a contemporary drug-eluting stent (DES) with regard to target lesion and target vessel failure ...
Sep 3, 2024
0
0









